IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-1464

  1. 1,869 Posts.
    lightbulb Created with Sketch. 1472
    BOT making big moves as its Phase 2A Staph trial has guidance to finish 4CY 2020 with results Q1 2021.

    That one had a successful In Vitro last year that pushed the SP into the 20c range iirc.

    When our oppies overhang is gone and we are cashed up to head into our Phase 2B OSA trial.... anytime now.
    Should see some interest there. Punters will become more attracted the closer it gets to completion date...
    Last edited by Exalted: 14/09/20
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.